Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2010
09/29/2010CN101297974B Pegylated glycosides of aerial parts of epimedium, and preparation and use thereof
09/29/2010CN101278926B Applications of iron chelator in preparation of medicament for preventing or curing hemorrhagic cerebrovascular disease and chronic hydrocephalus after craniocerebral injury
09/29/2010CN101269058B Spraying agent containing diclofenac acid and uses thereof
09/29/2010CN101249246B Proprietary Chinese medicine preparations for curing depression after cerebral infarction
09/29/2010CN101249131B Gynostemma pentaphylla effective ingredient extract
09/29/2010CN101244204B Suppository for treating hemorrhoid
09/29/2010CN101244060B Leonurus heterophyllus alkaloid composition
09/29/2010CN101214344B Chinese medicine preparation for treating coronary disease and stenocardia and preparation thereof
09/29/2010CN101209256B Polydatin medicinal composition containing polyvinyl pyrrolidone
09/29/2010CN101129469B Traditional Chinese medicine composition for preventing and controlling cardiovascular disease
09/29/2010CN101112405B Drug for curing coronary disease and method for preparing the same
09/29/2010CN101103964B Sustained-release preparation containing felodipine and preparation method thereof
09/29/2010CN101085809B Synthetic and preparing technique for Batifeiban and analogue
09/29/2010CN101084989B Method for preparing general flavone and total alkaloid of sophora flavescens simultaneously
09/29/2010CN101035548B Steroidal saponin pharmaceutical composition, the preparation method and use thereof
09/28/2010US7803954 Mandelic acid derivatives and their use as thrombin inhibitors
09/28/2010US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors
09/28/2010US7803807 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics
09/28/2010US7803795 and nitric oxide synthase inhibitor; e.g. 1-(phenylmethyl)-4-piperidyl-6-phthalazine-3one; antiinflammatory agent; preserve the cellular energy level: survival of ischaemic tissues after insult; neurodegenerative diseases: stroke, Alzheimer's and Parkinson's diseases, atherosclerosis, osteoarthritis
09/28/2010US7803780 gene therapy of transferring the CD9 gene for suppressing cardiac hypertrophy or cardiac tachycardia in a patient having a heart disease; viral or non-viral expression vector containing a sequence encoding a CD9 protein
09/28/2010US7803776 Combined use of enzyme inhibitors and of pharmaceutical compositions thereof
09/28/2010US7803772 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity
09/28/2010US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response
09/28/2010US7803615 Death domain containing receptor 5
09/28/2010US7803595 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/28/2010US7803560 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist
09/28/2010US7803408 Use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium
09/28/2010US7803399 Delivery system for nucleic acids
09/28/2010US7803183 Medical device with coating that promotes endothelial cell adherence
09/28/2010CA2562992C Probucol analogues, and use thereof as anti-inflammatory inhibitors of vcam-1
09/28/2010CA2481707C Benzopyran derivatives substituted with secondary amines having tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
09/28/2010CA2474430C A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction
09/28/2010CA2464758C Combination therapy comprising zd6474 and a taxane
09/28/2010CA2450915C Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure
09/28/2010CA2448038C Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
09/28/2010CA2407633C Method and compositions for inhibiting arteriosclerosis
09/28/2010CA2395772C Sulfonamide-containing heterocyclic compounds
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/28/2010CA2383257C Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
09/23/2010WO2010108001A2 Agents and methods for tissue repair and regeneration
09/23/2010WO2010107380A1 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions
09/23/2010WO2010107081A1 Solid preparation stably preserved in packaging
09/23/2010WO2010106988A1 Amide derivative
09/23/2010WO2010106519A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
09/23/2010WO2010106494A1 Use of pharmaceutical compositions containing mesembrenone
09/23/2010WO2010106437A1 Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same
09/23/2010WO2010105770A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/23/2010WO2010105750A1 Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency
09/23/2010WO2010073011A3 Heterocyclic compounds and their use as ampk activators
09/23/2010WO2010065069A3 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system related disorders
09/23/2010WO2010062824A3 Enhanced bioactive formulations of resveratrol
09/23/2010WO2010059245A3 Compositions and methods for treating or preventing radiation injury
09/23/2010WO2010058926A3 Pharmaceutical composition containing ginger extract or shogaol
09/23/2010WO2010056767A8 Thiochromene derivatives as hif hydroxylase inhibitors
09/23/2010WO2009127948A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
09/23/2010US20100240893 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
09/23/2010US20100240760 Biomarkers for Efficacy of Aliskiren as a Hypertensive Agent
09/23/2010US20100240742 Anti-angiogenic compositions and methods of use
09/23/2010US20100240740 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
09/23/2010US20100240735 Pharmaceutical Compositions for Angiogenic Therapy
09/23/2010US20100240728 Co-Crystals of Pyrrolidinones
09/23/2010US20100240704 Method of modulating stress-activated protein kinase system
09/23/2010US20100240703 Oxyimino compounds and the use thereof
09/23/2010US20100240702 Benzimidazolone Chymase Inhibitors
09/23/2010US20100240700 Prophylactic pretreatment with antioxidants
09/23/2010US20100240684 Minoxidil aqueous composition containing bile acid
09/23/2010US20100240683 Combination therapy, composition and methods for the treatment of cardiovascular disorders
09/23/2010US20100240679 4-Phenylpiperidine Derivatives as Renin Inhibitors
09/23/2010US20100240670 4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application
09/23/2010US20100240660 New histone deacetylases inhibitors
09/23/2010US20100240656 Compounds as hsp90 inhibitors
09/23/2010US20100240654 Hydrazide derivatives
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240646 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
09/23/2010US20100240644 Morpholine derivative
09/23/2010US20100240641 Aldosterone Synthase and/or 11B-hydroxylase Inhibitors
09/23/2010US20100240635 Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
09/23/2010US20100240634 Fluorene Compound and Pharmaceutical Use Thereof
09/23/2010US20100240622 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
09/23/2010US20100240620 3-Cyano-5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases
09/23/2010US20100240615 Nitric oxide donors
09/23/2010US20100240614 Indole Compounds Bearing Aryl or Heteroaryl Groups Having Sphingosine 1-Phosphate (S1P) Receptor Biological Activity
09/23/2010US20100240610 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
09/23/2010US20100240606 Associations of xanthogenates and cyclodextrins, and their use
09/23/2010US20100240603 Expression inhibitor of nuclear transcription factor ap-1 and pharmaceuticals and products using the same
09/23/2010US20100240583 Soluble protein and utilization of the same
09/23/2010US20100240580 Azoloarine derivatives, method for the production thereof, pharmaceuticals containing these compounds and the use thereof
09/23/2010US20100239694 compositions of Acai fruit and Jucara fruit with high antioxidant capability and cyclooxygenase-inhibitory activity, and their uses
09/23/2010US20100239669 Combinations of statins and anti-obesity agent
09/23/2010US20100239646 Sublingual methotrexate and methotrexate patches
09/23/2010US20100239636 Methods and Devices for Delivering Therapeutic Agents to Target Vessels
09/23/2010US20100239603 Combinations of Botanical Extracts for Promoting Cardiovascular Health
09/23/2010US20100239589 Methods and Compositions for Ameliorating Diabetes and Symptoms Thereof
09/23/2010US20100239576 Amino ester derivatives, sailts thereof and methods of use
09/23/2010US20100239573 METHOD OF INHIBITING COMPLEMENT ACTIVATION WITH FACTOR Bb SPECIFIC ANTIBODIES
09/23/2010US20100239569 Method Of Treating Disorders Of The Cardiovascular System And A Pharmaceutical Agent
09/23/2010US20100239567 Antibody Formulation
09/23/2010US20100239558 Lipid Hydrolysis Therapy for Atherosclerosis and Related Diseases
09/23/2010US20100239554 Extended recombinant polypeptides and compositions comprising same
1 ... 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 ... 1595